Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Yong-Qing Zheng"'
Publikováno v:
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
BACKGROUND Angiogenesis plays a significant role in complex inflammatory and angiogenic processes and is also involved in multiple myeloma (MM) pathogenesis. IL-37 is a proinflammatory cytokine in antitumor activity. Our purpose was to evaluate the I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0ff9ac617647e2b0a1d8c80307bea93
https://doi.org/10.12659/msm.897451
https://doi.org/10.12659/msm.897451
Autor:
Jingying Nong, Xi Li, Deruo Liu, Quan Zhang, Jia-lin Lü, Huiyi Yang, Lifen Ren-Heidenreich, Shucai Zhang, Yi-fen Sun, Na Qin, Shanqing Li, Xinjie Yang, Yuhua Wu, Hui Zhang, Yong-Qing Zheng, Xinyong Zhang
Publikováno v:
The Journal of Molecular Diagnostics. 15:819-826
Somatic DNA mutations affecting the epidermal growth factor receptor (EGFR) signaling pathway are known to predict responsiveness to EGFR-tyrosine kinase inhibitor drugs in patients with advanced non-small-cell lung cancers. We evaluated a sensitive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fed9f58532fb93fd444fefe13da4f538
https://doi.org/10.1016/j.jmoldx.2013.06.006
https://doi.org/10.1016/j.jmoldx.2013.06.006
Autor:
Jin Ping Zhang, Xin Ming Yan, Kun Xian Yang, Rong Xia Zuo, Tao Shou, Rong Zeng, Tao Shen, Yong Qing Zheng
Publikováno v:
Therapeutics and Clinical Risk Management
Rong Zeng,1–3 Tao Shou,3 Kun-xian Yang,4 Tao Shen,5 Jin-ping Zhang,5 Rong-xia Zuo,5 Yong-qing Zheng,5 Xin-ming Yan5 1Faculty of Environmental Science and Engineering, Kunming University of Science and Technology, Kunming, People’s Republic of Chi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24c3012990dae990297cc0a0eda67f72
https://www.dovepress.com/papillary-thyroid-carcinoma-risk-factors-in-the-yunnan-plateau-of-sout-peer-reviewed-article-TCRM
https://www.dovepress.com/papillary-thyroid-carcinoma-risk-factors-in-the-yunnan-plateau-of-sout-peer-reviewed-article-TCRM
Publikováno v:
Journal of Cancer Research and Therapeutics, Vol 8, Iss 3, Pp 343-347 (2012)
The fatality rate of esophageal carcinomas is high in developing countries, making effective treatment desirable. Traditional treatment has now entered into the platform, and treatments based on the detection of biomarkers increasingly become a trend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e089164eff385ef7f48acb8937e33c51
http://www.cancerjournal.net/article.asp?issn=0973-1482
http://www.cancerjournal.net/article.asp?issn=0973-1482
Autor:
Xiao-Yu, Li, Jian-Zhen, Shen, Song-Fei, Shen, Hai-Ying, Fu, Hua-Rong, Zhou, Dan-Sen, Wu, Yuan-Yuan, Zhang, Yong-Qing, Zheng
Publikováno v:
Zhongguo shi yan xue ye xue za zhi. 19(2)
This study was to purposed to explore the methylation status changes of IEX-1 gene promoter CpG island and its relevance with occurrence of hematologic malignancies. The methylation status of IEX-1 gene promoter CpG island in 9 NB4, HL-60 U937, Raji,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1bf647757234994cfd2880d38d3b7577
https://pubmed.ncbi.nlm.nih.gov/21518511
https://pubmed.ncbi.nlm.nih.gov/21518511
Autor:
Yuan-Yuan, Zhang, Yong-Qing, Zheng, Xiao-Yu, Li, Dan-Sen, Wu, Shui-Ling, Xie, Jian-Zhen, Shen
Publikováno v:
Zhongguo shi yan xue ye xue za zhi. 19(2)
MicroRNA abnormality is closely related to the development of acute leukemia. This study was aimed to investigate the differential expression of miR-143 in bone marrow cells between patients with acute leukemia and normal people. Bone marrow cells fr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::084414970b60bd969afe63fe36f91349
https://pubmed.ncbi.nlm.nih.gov/21518477
https://pubmed.ncbi.nlm.nih.gov/21518477
Autor:
Rong Zeng, Tao Shou, Kun-xian Yang, Tao Shen, Jin-ping Zhang, Rong-xia Zuo, Yong-qing Zheng, Xin-ming Yan, Zeng, Rong, Shou, Tao, Yang, Kun-Xian, Shen, Tao, Zhang, Jin-Ping, Zuo, Rong-Xia, Zheng, Yong-Qing, Yan, Xin-Ming
Publikováno v:
Therapeutics & Clinical Risk Management; Jun2016, Vol. 12, p1065-1074, 10p
Autor:
Yong-Qing Zheng, Huiyi Yang, Gang Yu, Jiasen Xu, Shucai Zhang, Xinjie Yang, Xi Li, Na Qin, Hui Zhang
Publikováno v:
Journal of Clinical Oncology. 30:e18142-e18142
e18142 Background: Responsiveness of non-small cell lung cancer (NSCLC) to EGFR tyrosine kinase inhibitors has been confirmed to relate to mutations in the epidermal growth factor receptor (EGFR) signaling pathway genes. This study’s aim is to dete
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a228944ae95ab88c1b2e543b1a33efa8
https://doi.org/10.1200/jco.2012.30.15_suppl.e18142
https://doi.org/10.1200/jco.2012.30.15_suppl.e18142
Autor:
Zhen-Yi Lu, Yong-Qing Zheng, Wang Xiao Jia, Yi-Ping Zhang, Jing Qin, Wei-Wu Ye, Xinmin Yu, Qiao-Yuan Cheng, Weimin Mao, CaiJin Lou, Lei Lei, Zeng Wang, Hongyang Lu, Ju-Fen Cai
Publikováno v:
Journal of Clinical Oncology. 30:e17512-e17512
e17512 Background: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) has been widely used in non-small cell lung cancer (NSCLC), and the incidence of EGFR mutation in NSCLC is higher in China than in the United States and Europe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55c83c0a8530391765d9a13be1fa3109
https://doi.org/10.1200/jco.2012.30.15_suppl.e17512
https://doi.org/10.1200/jco.2012.30.15_suppl.e17512
Publikováno v:
World Chinese Journal of Digestology. 18:1331
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::373bf140c6b068f8f3c34d398085bddb
https://doi.org/10.11569/wcjd.v18.i13.1331
https://doi.org/10.11569/wcjd.v18.i13.1331